APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Propofol Medium/Long Chain Fat Emulsion Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Propofol Medium/Long Chain Fat Emulsion Injection Market Analysis and Forecast 2026-2032

Report ID 174029180229 December 2025190 pages

Choose your research edition.

Industry ResearchPropofol Medium/Long Chain Fat Emulsion Injection Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Medium/Long Chain Fat Emulsion Injection Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Propofol Medium/Long Chain Fat Emulsion Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Medium/Long Chain Fat Emulsion Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Medium/Long Chain Fat Emulsion Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Propofol Medium/Long Chain Fat Emulsion Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Propofol Medium/Long Chain Fat Emulsion Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Propofol Medium/Long Chain Fat Emulsion Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Propofol Medium/Long Chain Fat Emulsion Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Propofol Medium/Long Chain Fat Emulsion Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Propofol Medium/Long Chain Fat Emulsion Injection include Pfizer, AstraZeneca, Wellona Pharma, Rusoma Laboratories, Neon Laboratories Limited, Fresenius Kabi Deutschland GmbH, Centurion Healthcare Private Limited and B.Braun Melsungen AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Propofol Medium/Long Chain Fat Emulsion Injection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Propofol Medium/Long Chain Fat Emulsion Injection, also provides the revenue of main regions and countries. Of the upcoming market potential for Propofol Medium/Long Chain Fat Emulsion Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Propofol Medium/Long Chain Fat Emulsion Injection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Propofol Medium/Long Chain Fat Emulsion Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Propofol Medium/Long Chain Fat Emulsion Injection revenue, projected growth trends, production technology, application and end-user industry.

Propofol Medium/Long Chain Fat Emulsion Injection Segment by Company

Pfizer

AstraZeneca

Wellona Pharma

Rusoma Laboratories

Neon Laboratories Limited

Fresenius Kabi Deutschland GmbH

Centurion Healthcare Private Limited

B.Braun Melsungen AG

Propofol Medium/Long Chain Fat Emulsion Injection Segment by Type

10ml：0.1g

20ml：0.2g

50ml：0.5g

100ml：1.0g

Others

Propofol Medium/Long Chain Fat Emulsion Injection Segment by Application

Hospital

Clinic

Others

Propofol Medium/Long Chain Fat Emulsion Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Medium/Long Chain Fat Emulsion Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Medium/Long Chain Fat Emulsion Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Medium/Long Chain Fat Emulsion Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Propofol Medium/Long Chain Fat Emulsion Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Propofol Medium/Long Chain Fat Emulsion Injection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Propofol Medium/Long Chain Fat Emulsion Injection revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10ml：0.1g Major Player Table 3. 20ml：0.2g Major Player Table 4. 50ml：0.5g Major Player Table 5. 100ml：1.0g Major Player Table 6. Others Major Player Table 7. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Player Table 9. Clinic Major Player Table 10. Others Major Player Table 11. Propofol Medium/Long Chain Fat Emulsion Injection Industry Trends Table 12. Propofol Medium/Long Chain Fat Emulsion Injection Industry Drivers Table 13. Propofol Medium/Long Chain Fat Emulsion Injection Industry Opportunities and Challenges Table 14. Propofol Medium/Long Chain Fat Emulsion Injection Industry Restraints Table 15. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Share by Region (2021-2026) Table 18. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Share by Region (2027-2032) Table 20. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Players (2021-2026) Table 22. Global Propofol Medium/Long Chain Fat Emulsion Injection Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Propofol Medium/Long Chain Fat Emulsion Injection Key Players Headquarters & Area Served Table 24. Global Propofol Medium/Long Chain Fat Emulsion Injection Players, Product Type & Application Table 25. Global Propofol Medium/Long Chain Fat Emulsion Injection Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Propofol Medium/Long Chain Fat Emulsion Injection by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Type (2021-2026) Table 32. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Type (2027-2032) Table 33. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Application (2021-2026) Table 37. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Application (2027-2032) Table 38. Pfizer Company Information Table 39. Pfizer Business Overview Table 40. Pfizer Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Pfizer Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 42. Pfizer Recent Development Table 43. AstraZeneca Company Information Table 44. AstraZeneca Business Overview Table 45. AstraZeneca Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. AstraZeneca Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 47. AstraZeneca Recent Development Table 48. Wellona Pharma Company Information Table 49. Wellona Pharma Business Overview Table 50. Wellona Pharma Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Wellona Pharma Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 52. Wellona Pharma Recent Development Table 53. Rusoma Laboratories Company Information Table 54. Rusoma Laboratories Business Overview Table 55. Rusoma Laboratories Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Rusoma Laboratories Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 57. Rusoma Laboratories Recent Development Table 58. Neon Laboratories Limited Company Information Table 59. Neon Laboratories Limited Business Overview Table 60. Neon Laboratories Limited Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Neon Laboratories Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 62. Neon Laboratories Limited Recent Development Table 63. Fresenius Kabi Deutschland GmbH Company Information Table 64. Fresenius Kabi Deutschland GmbH Business Overview Table 65. Fresenius Kabi Deutschland GmbH Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Fresenius Kabi Deutschland GmbH Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 67. Fresenius Kabi Deutschland GmbH Recent Development Table 68. Centurion Healthcare Private Limited Company Information Table 69. Centurion Healthcare Private Limited Business Overview Table 70. Centurion Healthcare Private Limited Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Centurion Healthcare Private Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 72. Centurion Healthcare Private Limited Recent Development Table 73. B.Braun Melsungen AG Company Information Table 74. B.Braun Melsungen AG Business Overview Table 75. B.Braun Melsungen AG Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. B.Braun Melsungen AG Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio Table 77. B.Braun Melsungen AG Recent Development Table 78. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026) & (US$ Million) Table 79. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032) & (US$ Million) Table 80. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026) & (US$ Million) Table 81. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032) & (US$ Million) Table 82. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021-2026) & (US$ Million) Table 84. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (US$ Million) & (2027-2032) Table 85. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026) & (US$ Million) Table 86. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032) & (US$ Million) Table 87. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026) & (US$ Million) Table 88. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032) & (US$ Million) Table 89. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (US$ Million) & (2027-2032) Table 92. China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026) & (US$ Million) Table 93. China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032) & (US$ Million) Table 94. China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026) & (US$ Million) Table 95. China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032) & (US$ Million) Table 96. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026) & (US$ Million) Table 97. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032) & (US$ Million) Table 98. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026) & (US$ Million) Table 99. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Region (US$ Million) & (2021-2026) Table 102. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Region (US$ Million) & (2027-2032) Table 103. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026) & (US$ Million) Table 104. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032) & (US$ Million) Table 105. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026) & (US$ Million) Table 106. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032) & (US$ Million) Table 107. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021-2026) & (US$ Million) Table 109. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (US$ Million) & (2027-2032) Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Propofol Medium/Long Chain Fat Emulsion Injection Image Figure 2. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10ml：0.1g Image Figure 5. 20ml：0.2g Image Figure 6. 50ml：0.5g Image Figure 7. 100ml：1.0g Image Figure 8. Others Image Figure 9. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size (US$ Million) & (2021-2032) Figure 15. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Propofol Medium/Long Chain Fat Emulsion Injection Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Propofol Medium/Long Chain Fat Emulsion Injection Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Type (2021-2032) Figure 22. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032) Figure 27. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032) Figure 28. North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Country (2021-2032) Figure 29. United States Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032) Figure 34. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032) Figure 35. Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Country (2021-2032) Figure 36. Germany Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032) Figure 46. China Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032) Figure 47. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032) Figure 49. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032) Figure 50. Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Region (2021-2032) Figure 51. Japan Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032) Figure 59. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032) Figure 60. SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Country (2021-2032) Figure 61. Brazil Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Propofol Medium/Long Chain Fat Emulsion Injection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml：0.1g
  • 20ml：0.2g
  • 50ml：0.5g
  • 100ml：1.0g
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Pfizer
  • AstraZeneca
  • Wellona Pharma
  • Rusoma Laboratories
  • Neon Laboratories Limited
  • Fresenius Kabi Deutschland GmbH
  • Centurion Healthcare Private Limited
  • B.Braun Melsungen AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Propofol Medium/Long Chain Fat Emulsion Injection Market by Type
  3. 1.2.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10ml：0.1g
  5. 1.2.3 20ml：0.2g
  6. 1.2.4 50ml：0.5g
  7. 1.2.5 100ml：1.0g
  8. 1.2.6 Others
  9. 1.3 Propofol Medium/Long Chain Fat Emulsion Injection Market by Application
  10. 1.3.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Propofol Medium/Long Chain Fat Emulsion Injection Market Dynamics
  1. 2.1 Propofol Medium/Long Chain Fat Emulsion Injection Industry Trends
  2. 2.2 Propofol Medium/Long Chain Fat Emulsion Injection Industry Drivers
  3. 2.3 Propofol Medium/Long Chain Fat Emulsion Injection Industry Opportunities and Challenges
  4. 2.4 Propofol Medium/Long Chain Fat Emulsion Injection Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Perspective (2021-2032)
  2. 3.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Growth Trends by Region
  3. 3.2.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Region (2021-2026)
  5. 3.2.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Players
  2. 4.1.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Players (2021-2026)
  3. 4.1.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Key Players Headquarters & Area Served
  7. 4.4 Global Propofol Medium/Long Chain Fat Emulsion Injection Players, Product Type & Application
  8. 4.5 Global Propofol Medium/Long Chain Fat Emulsion Injection Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Market CR5 and HHI
  11. 4.6.3 2025 Propofol Medium/Long Chain Fat Emulsion Injection Tier 1, Tier 2, and Tier 3
5 Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Type
  1. 5.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2032)
  3. 5.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Type (2021-2032)
6 Propofol Medium/Long Chain Fat Emulsion Injection Market Size by Application
  1. 6.1 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2032)
  3. 6.3 Global Propofol Medium/Long Chain Fat Emulsion Injection Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 AstraZeneca
  8. 7.2.1 AstraZeneca Company Information
  9. 7.2.2 AstraZeneca Business Overview
  10. 7.2.3 AstraZeneca Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  12. 7.2.5 AstraZeneca Recent Developments
  13. 7.3 Wellona Pharma
  14. 7.3.1 Wellona Pharma Company Information
  15. 7.3.2 Wellona Pharma Business Overview
  16. 7.3.3 Wellona Pharma Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Wellona Pharma Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  18. 7.3.5 Wellona Pharma Recent Developments
  19. 7.4 Rusoma Laboratories
  20. 7.4.1 Rusoma Laboratories Company Information
  21. 7.4.2 Rusoma Laboratories Business Overview
  22. 7.4.3 Rusoma Laboratories Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Rusoma Laboratories Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  24. 7.4.5 Rusoma Laboratories Recent Developments
  25. 7.5 Neon Laboratories Limited
  26. 7.5.1 Neon Laboratories Limited Company Information
  27. 7.5.2 Neon Laboratories Limited Business Overview
  28. 7.5.3 Neon Laboratories Limited Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Neon Laboratories Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  30. 7.5.5 Neon Laboratories Limited Recent Developments
  31. 7.6 Fresenius Kabi Deutschland GmbH
  32. 7.6.1 Fresenius Kabi Deutschland GmbH Company Information
  33. 7.6.2 Fresenius Kabi Deutschland GmbH Business Overview
  34. 7.6.3 Fresenius Kabi Deutschland GmbH Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Fresenius Kabi Deutschland GmbH Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  36. 7.6.5 Fresenius Kabi Deutschland GmbH Recent Developments
  37. 7.7 Centurion Healthcare Private Limited
  38. 7.7.1 Centurion Healthcare Private Limited Company Information
  39. 7.7.2 Centurion Healthcare Private Limited Business Overview
  40. 7.7.3 Centurion Healthcare Private Limited Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Centurion Healthcare Private Limited Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  42. 7.7.5 Centurion Healthcare Private Limited Recent Developments
  43. 7.8 B.Braun Melsungen AG
  44. 7.8.1 B.Braun Melsungen AG Company Information
  45. 7.8.2 B.Braun Melsungen AG Business Overview
  46. 7.8.3 B.Braun Melsungen AG Propofol Medium/Long Chain Fat Emulsion Injection Revenue and Gross Margin (2021-2026)
  47. 7.8.4 B.Braun Melsungen AG Propofol Medium/Long Chain Fat Emulsion Injection Product Portfolio
  48. 7.8.5 B.Braun Melsungen AG Recent Developments
8 North America
  1. 8.1 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue (2021-2032)
  2. 8.2 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2032)
  3. 8.2.1 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026)
  4. 8.2.2 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032)
  5. 8.3 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032)
  6. 8.4 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2032)
  7. 8.4.1 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026)
  8. 8.4.2 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032)
  9. 8.5 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032)
  10. 8.6 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country
  11. 8.6.1 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021-2026)
  13. 8.6.3 North America Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue (2021-2032)
  2. 9.2 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2032)
  3. 9.2.1 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026)
  4. 9.2.2 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032)
  5. 9.3 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032)
  6. 9.4 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2032)
  7. 9.4.1 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026)
  8. 9.4.2 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032)
  9. 9.5 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032)
  10. 9.6 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country
  11. 9.6.1 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021-2026)
  13. 9.6.3 Europe Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Propofol Medium/Long Chain Fat Emulsion Injection Revenue (2021-2032)
  2. 10.2 China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2032)
  3. 10.2.1 China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026)
  4. 10.2.2 China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032)
  5. 10.3 China Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032)
  6. 10.4 China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2032)
  7. 10.4.1 China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026)
  8. 10.4.2 China Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032)
  9. 10.5 China Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue (2021-2032)
  2. 11.2 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2032)
  3. 11.2.1 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026)
  4. 11.2.2 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032)
  5. 11.3 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032)
  6. 11.4 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2032)
  7. 11.4.1 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026)
  8. 11.4.2 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032)
  9. 11.5 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032)
  10. 11.6 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country
  11. 11.6.1 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021-2026)
  13. 11.6.3 Asia Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue (2021-2032)
  2. 12.2 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Type (2027-2032)
  5. 12.3 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Application (2027-2032)
  9. 12.5 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country
  11. 12.6.1 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Propofol Medium/Long Chain Fat Emulsion Injection Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst